Fundz

Hedera Dx Raises €14M In Seed Funding Round Led By Top Harvest Founder Ghobarah

PRIVATESep 21, 2022

Amount Raised

€14 Million

Round Type

Seed

VaudBiotechnologyHealth CareMedical

Description

Swiss techbio company Hedera Dx, founded in 2021 by veteran healthcare entrepreneurs and executives, has raised€14 million a seed finding round led by Adam Ghobarah, founder of Top Harvest Capital and former longtime executive at Google and Google Ventures.

Quick answer

Hedera Dx raised €14 Million in a Seed round, dated September 21, 2022. Hedera Dx is based in Vaud, Switzerland.

How much did Hedera Dx raise?
Hedera Dx raised €14 Million in a Seed round on September 21, 2022.
What does Hedera Dx do?
Life-saving information for cancer patients when it matters most 1 in 3 people will be diagnosed with cancer in their lifetime (according to cancer.org).
Where is Hedera Dx based and how big is it?
Hedera Dx is based in Vaud, Switzerland.

Source: Fundz verified event record.

Who to call at Hedera Dx, and when

A new round usually means Hedera Dx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Hedera Dx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hedera Dx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hedera Dx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hedera Dx

Location

Vaud, Switzerland

About

Life-saving information for cancer patients when it matters most 1 in 3 people will be diagnosed with cancer in their lifetime (according to cancer.org). Therefore, it is critical to detect it early, when it matters most and it’s still curable. Hedera Dx was born to actively contribute to this paradigm shift. Headquartered in Lausanne’s Biopôle, Switzerland, Hedera Dx was created in 2021 with the mission to give access to liquid biopsy technologies to patients at risk of or already suffering from cancer. Co-founded by Tommi Lehtonen, Damien Lapray and Christian Meisel, Hedera Dx is an ambitious, fast growing and passionate scale-up employing 15+ people across Switzerland and Europe. 🔬 Liquid biopsy tests are powerful blood-based technologies for cancer diagnosis and they are starting to enter the clinic. The information gathered from these analyses will take our awareness of cancer to the next level unlocking new possibilities of diagnosis and care. However, all of these new technologies add a lot of complexities to the daily clinical workflow requiring new tools for easy access and usability. 🔍 The Hedera Dx platform, Hedera Prime, solves that challenge, giving a streamlined experience for clinicians to use liquid biopsy tests in early detection, therapy selection and recurrence monitoring.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hedera Dx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Hedera Dx's next move

See what Strategic adds

Hedera Dx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.